Ergomed Acquires Ashfield Pharmacovigilance Inc.

January 13, 2020
Applied Clinical Trials

Ergomed plc has announced the acquisition of Ashfield Pharmacovigilance Inc. from UDG Healthcare US Holdings, Inc. Ergomed has acquired the entire issued share capital of Ashfield PV for a total cash consideration of $10 million. 

For more information, click here.